Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial ; day:8 ; month:1 ; year:2020 ; pages:1-7
Clinical research in cardiology ; (8.1.2020), 1-7
- Urheber
-
Kozieł, Monika
Al-Saady, Naab
Hjortshøj, Søren P.
Goudev, Assen
Huber, Kurt
Cohen, Ariel
Jin, James
Melino, Michael
Winters, Shannon M.
Goette, Andreas
Lip, Gregory Y. H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-019-01594-9
- URN
-
urn:nbn:de:101:1-2020041403310981183859
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kozieł, Monika
- Al-Saady, Naab
- Hjortshøj, Søren P.
- Goudev, Assen
- Huber, Kurt
- Cohen, Ariel
- Jin, James
- Melino, Michael
- Winters, Shannon M.
- Goette, Andreas
- Lip, Gregory Y. H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Grimmen - 1983 "Warfarin"
Der Vitamin-K-Antagonist Warfarin verursacht kardiovaskuläre Schäden bei Mäusen
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Effect of Warfarin, Warfarin Enantiomers and Defibrase on Lewis Lung Carcinoma Metastasis Growth in Mice
Systematic Review of Pharmacogenetic Warfarin Dosing
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Grimmen - 1983 "Warfarin"
Der Vitamin-K-Antagonist Warfarin verursacht kardiovaskuläre Schäden bei Mäusen
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Effect of Warfarin, Warfarin Enantiomers and Defibrase on Lewis Lung Carcinoma Metastasis Growth in Mice
Systematic Review of Pharmacogenetic Warfarin Dosing
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Rivaroxaban versus warfarin for the management of left ventricle thrombus
Grimmen - 1983 "Warfarin"
Der Vitamin-K-Antagonist Warfarin verursacht kardiovaskuläre Schäden bei Mäusen
International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Application of rapid genotyping of Warfarin individualized pharmacogenetic variants in Warfarin therapy
Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
Effect of Warfarin, Warfarin Enantiomers and Defibrase on Lewis Lung Carcinoma Metastasis Growth in Mice
Systematic Review of Pharmacogenetic Warfarin Dosing